$ENZ

Enzo Biochem, Inc.

  • NEW YORK STOCK EXCHANGE INC.
  • Health Technology
  • Biotechnology
  • Professional, Scientific, and Technical Services
  • Testing Laboratories

PRICE

$2.9 ▲28.319%

Extented Hours

VOLUME

75,530

DAY RANGE

2.21 - 2.42

52 WEEK

2.17 - 4.15

Join Discuss about ENZ with like-minded investors

profile
@dros #droscrew
recently

Top Earnings Wed 12/15 Aft: $BLBD $ENZ $HEI $IRNT $JOBS $LEN $NDSN $TCOM . Top Earnings Th 12/16 Pre: $ACN $ADBE $JBL $NM $TNP $WOR

74 Replies 8 👍 11 🔥

profile
@DarkPoolAlgo #Dark Pool Charts
recently

Monday, October 11, 2021 U.S. stock futures are edging lower ahead of the Columbus Day holiday, with oil prices extending last week gains and moving to fresh 7-year highs ahead of key inflation data later this week and the upcoming earnings season, which starts Friday with the big banks ($JPM, $Citi). Over the weekend, Goldman Sachs cuts its 2021 economic growth forecast by 10 basis points, to 5.6%, while lowering its 2022 estimate by 40 basis point to 4% citing a “longer lasting virus drag on virus-sensitive consumer services” and the impact of an extended shortage in global semiconductors. The bond market is closed today in observance of the Columbus Day holiday after the 10-year yield closed at 1.612% on Friday, the highest level of the week. Oil prices extending gains, as WTI crude rises over $2.20 or 2.8% above $81.50. In Asian markets, The Nikkei Index rose 449 points (1.6%%) to 28,498, the Shanghai Index was little changed at 3,591, and the Hang Seng Index jumped nearly 2% or 487 points to settle at 25,325. In Europe, the German DAX is down about -50 points to 15,150, while the FTSE 100 is up about 0.25% at 7,110. Q quiet day expected ahead with no economic data and bond markets closed. Market Closing Prices Yesterday · The S&P 500 Index dropped -8.42 points, or 0.19%, to 4,391.34 · The Dow Jones Industrial Average fell -8.69 points, or 0.03%, to 34,746.25 The Nasdaq Composite slid -74.48 points, or 0.51%, to 14,579.54 · The Russell 2000 Index declined -17.00 points, or 0.76% to 2,233.09 Events Calendar for Today · No Major Economic Data Earnings Calendar: · Earnings Before the Open: AZZ, ENZ, FAST · Earnings After the Close: PNFP, SGH Other Key Events: · American Society of Retina Specialists Annual Scientific Meeting, in San Antonio, TX 10/8-10/12 World News · Goldman Sachs cuts its forecast for U.S economic growth over the weekend, citing a “longer lasting virus drag on virus-sensitive consumer services” and the impact of an extended shortage in global semiconductors. Goldman trimmed its 2021 growth forecast by 10 basis points, to 5.6%, while lowering its 2022 estimate by 40 basis point to 4%, adding that consumer spending is likely to be held back by pandemic uncertainty and a softer-than-expected fiscal response from the Biden administration. · Taiwan will keep bolstering its defenses to ensure nobody can force them to accept the path China has laid down that offers neither freedom nor democracy, President Tsai Ing-wen said on Sunday – Reuters Sector News Breakdown Consumer · Southwest Airlines ($LUV) cancelled 808 flights yesterday and has cancelled another 1,006 today, according to data from Flightaware.com. The company blamed the disruption on air traffic control issues and weather, although other major airlines are not delaying or cancelling flights at an elevated rate. There was speculation that some Southwest employees have called in sick in a form of protest over the mandatory vaccination rules in place, which have been unconfirmed · Hasbro ($HAS) said CEO Brian Goldner will take a medical leave of absence, effective immediately, slightly more than a year after disclosing that he was undergoing continued medical care following treatment for cancer in 2014. Energy, Industrials and Materials · Honeywell ($HON) raised its business outlook for jet deliveries on Sunday as travel restrictions ease as they now see 7,400 new business jet deliveries worth $238 bln over the next 10 years, up 1% from the same 10-year forecast a year ago. Business jet operators surveyed by Honeywell reported a sharp increase in their used jet purchase plans, 12% above last year’s report · Emerson Electric ($EMR) plans to merge two of its software businesses with Aspen Technology (AZPN) in a roughly $11B deal that values Aspen at around $160 a share, as shareholders would receive $87 and 0.42 share of the combined company for each share they currently own – WSJ https://on.wsj.com/3FxyVx7 · Cleveland-Cliffs ($CLF) agrees to acquire Ferrous Processing and Trading, one of the largest processors and distributors of prime ferrous scrap in the U.S., in a deal with an enterprise value of ~$775M. · Tutor Perini’s ($TPC) joint-venture signed a contract valued at ~$178 million by the U.S. Department of the Interior, Bureau of Reclamation, for the Friant-Kern Canal Middle Reach Capacity Correction Phase I project in central California, southeast of Visalia. Financials · Prudential ($PRU) mentioned positively in Barron’s saying for many years, Prudential Financial’s stock had a nice yield, but it didn’t offer much capital appreciation. The pandemic didn’t help, as the shares lost about 12% last year, dividends included, versus an 18% return for the S&P 500 index. But the market has changed its view, partly owing to an uptick in rates. On top of that, Prudential, whose businesses include life insurance, variable annuities, and asset management, is getting some credit for more-consistent earnings in recent years. Healthcare · Supernus Pharmaceuticals, Inc. ($SUPN) to acquire Adamas Pharmaceuticals, Inc. (ADMS) through a tender offer for $8.10 per share in cash (or an aggregate of approximately $400 million), payable at closing plus two non-tradable contingent value rights (CVR) collectively worth up to $1.00 per share in cash (or an aggregate of approximately $50 million), for a total consideration of $9.10 per share in cash (or an aggregate of approximately $450 million). · AstraZeneca ($AZN) Phase 3 trial met its primary end point; trial showed a reduced risk of death & severe C-19 by 67% in a trial where 90% of participants were from high-risk categories; only long acting antibody combination that can both prevent & treat C-19 · Merck ($MRK) submitted an Emergency Use Authorization (EUA) application to the U.S. FDA for molnupiravir, an investigational oral antiviral medicine, for the treatment of mild-to-moderate COVID-19 who are at risk for progressing to severe COVID-19 and/or hospitalization · Regenxbio ($RGNX) announces initial data from the ongoing Phase II ALTITUDE trial of RGX-314 for the treatment of diabetic retinopathy (DR) without center-involved diabetic macular edema (CI-DME) using in-office suprachoroidal delivery. · BeiGene ($BGNE) announced that BRUKINSA has been approved in Australia for the treatment of adult patients with mantle cell lymphoma who have received at least one prior therapy Technology, Media & Telecom · Apple ($AAPL) asked a federal appeals court on Friday to throw out a legal decision that would require the tech giant to tweak its strict App Store rules and force it to allow app developers to inform customers of ways to pay for subscriptions and services outside the App Store – NYT · Gray Television ($GTN) a positive mention in Barron’s saying at about $23.50 a share, it has a price/earnings ratio of five based on 2022 estimates. It looks like an inexpensive way to bet on broadcast as Gray’s strength in local news helps it make a killing in political ads · Toshiba Corp ($6502.T) said it would announce the results of a strategic review of its business along with its quarterly earnings results and a new mid-term business plan on Nov. 12. A spokesperson said the results of Toshiba’s strategic review would be part of the new business plan. The company had previously said the review would be announced this month. · U.S.-listed Chinese tech stocks Alibaba ($BABA), JD.com ($JD) and Baidu ($BIDU) among market leaders early; BABA shares up over 5% after Reuters noted the Daily Journal Corp, chaired by Berkshire Hathaway Vice Chairman Charlie Munger, boosted its holdings in BABA by 83% during Q3, according to public disclosures. Also helping sentiment in China listed stocks, China’s antitrust regulator also fines delivery giant Meituan 3.4 bln yuan ($527.4 mln), a smaller than expected figure, for abusing its dominant market position · Comcast ($CMCSA) downgraded to Market Perform from Outperform at Raymond James

137 Replies 11 👍 13 🔥

profile
@viking #StockTraders.NET
recently

Upside: -ZIVO +24% (momentum following LD Micro Virtual conference) -SNGX +16% (receives Pediatric Investigational Plan Waiver for HyBryte™ in CTCL from the European Medicines Agency) -OXM +14% (earnings, guidance) -RH +8.0% (earnings, guidance) -SIG +7.7% (earnings, guidance; reinstates dividend at lower level) -ASAN +6.9% (momentum) -ENZ +5.6% (earnings) -VOR +4.4% (entered into a multi-year strategic collaboration with Abound Bio and license agreement to research both single- and multi-targeted CAR-T treatments) -TLYS +3.4% (declares $1.00/shr special cash dividend) -GEF +1.7% (earnings, guidance) Downside: -OCGN -40% (to pursue a BLA path in the US for its COVID-19 vaccine candidate; no longer pursuing EUA) -MTLS -14% (prices public offering of 4.0M ADS at $24.0 each for total gross proceedings of $96M) -KLXE -13% (earnings, guidance) -CELH -9.9% (prices 6.5M share offering at $62.50/shr) -FCEL -9.8% (earnings, guidance) -LAKE -7.4% (earnings) -GME -6.5% (earnings, guidance; discloses SEC document request related to investigation of trading activity in GME securities) -IMBI -5.4% (prices offer of 4.8M shares at $9.00/shr for total gross proceedings of $43.5M) -LTHM -3.4% (files to sell 12.5M shares via GS and JPM) -FSLY -2.3% (Oppenheimer Cuts FSLY to Perform from Outperform) -REVG -2.1% (files to sell 7.5M common share secondary offering)

122 Replies 10 👍 12 🔥

profile
@DarkPoolAlgo #Dark Pool Charts
recently

/*============================================= = Wednesday, June 9, 2021 = =============================================*/ Futures Up/Down % Last Dow -25.00 0.07% 34,561 S&P 500 2.25 0.05% 4,228 Nasdaq 28.50 0.20% 13,839 U.S. stock futures are mixed with Dow futures slipping, S&P futures flat and Nasdaq futures looking higher as Treasury yields fall to their lowest levels in weeks (1.50% for the 10-year) ahead of key inflation data later this week. Stock averages flirted with record highs on Tuesday, as the S&P neared but could not hold its early gains (ended Tuesday at 4,227, just off its closing high on May 7 of 4,232) while the Russell 2000 neared its all-time best close as investors appear wary ahead of inflation data due on Thursday in the form of consumer prices (CPI). Consumer discretionary and energy were the best performing major S&P 500 sectors on the day, while utilities were the weakest group. A lack of clear market catalysts kept institutional investors on the sidelines, while retail traders fueled the ongoing meme stocks rally with more volatility from the likes of AMC, GME, BBBY, WKHS, BB, with new names such as CLOV and WEN added to the fray. Fear remains non-existent in the market as the CBOE volatility index (VIX) touched its lowest level in over a year. It appears for the time being the “meme stocks” are taking over from crypto as the place to be as Bitcoin prices slid. Oil prices inch higher with WTI crude above $70 per barrel for the first time since October 2018 and Bitcoin rebounds. In Asian markets, The Nikkei Index fell -102 points to 28,860, the Shanghai Index rose 11 points to 3,591 and the Hang Seng Index dipped -38 points to 28,742. In Europe, the German DAX is down about -80 points to 15,555, while the FTSE 100 slides about -40 points to 7,050. China data showed May PPI +9.0% y/y vs +8.5% poll, +6.8% in April, May CPI +1.3% y/y vs +1.6% poll, +0.9% in April (CPI highest in eight months). Chinese stocks edge higher despite the fastest factory inflation since 2008 as benign CPI suggests only limited pass-through to consumers Market Closing Prices Yesterday The S&P 500 Index inched higher 0.74 points, or 0.02%, to 4,227.26 The Dow Jones Industrial Average fell -30.42 points, or 0.09%, to 34,599.82 The Nasdaq Composite gained 43.19 points, or 0.31%, to 13,924.91 The Russell 2000 Index advanced 24.58 points, or 1.06% to 2,343.76 Events Calendar for Today 7:00 AM ET MBA Mortgage Applications Data 10:00 AM EST Wholesale Inventories for April 10:30 AM ET Weekly DOE Inventory Data Earnings Calendar: Earnings Before the Open: BF/B, $CPB, $DAKT, $LOVE, $UNFI, $VRA Earnings After the Close: $ENZ, $GEF, $GME, $KLXE, $LAKE, $OXM, $RH, $TCL, $VRNT Other Key Events: Baird Global Consumer, Technology & Services Conference 2021 (virtual), 6/8-6/10 Deutsche Bank Global Consumer Conference (virtual), 6/7-6/10 Goldman Sachs Healthcare Conference (virtual), 6/8-6/10 Goldman Sachs 25th Annual European Financials Conference (virtual), 6/8-6/10 Jefferies Healthcare Virtual Conference, 6/8-6/10 Oppenheimer Virtual Software & Semiconductor Bus Tour, 6/7-6/11 Piper Global Exchange & FinTech Conference (virtual), 6/9-6/10 REITWeek 2021 Investor Virtual Conference, 6/8-6/10 UBS Global Industrials and Transportation Conference, 6/8-6/9 Macro Up/Down Last Nymex 0.11 70.16 Brent 0.12 72.34 Gold -2.60 1,890.25 EUR/USD 0.0019 1.2192 JPY/USD -0.06 109.44 10-Year Note -0.019 1.509% World News China’s factory gate prices rose at their fastest annual pace in over 12 years in May as the producer price index (PPI) increased 9.0% from a year earlier (est. 8.5%), the National Bureau of Statistics (NBS) said driven by significant price increases in crude oil, iron ore and non-ferrous metals. On a monthly basis, the PPI rose 1.6%, up from a 0.9 uptick in April. China’s consumer price index (CPI) rose 1.3% in May in annual terms, the biggest increase in eight months. That was still slower than analysts’ forecast for a 1.6% increase, after a 0.9% gain in April. S. Senate passed a wide ranging $250b Bill designed to counter China & compete with China Bipartisan group meeting, Republican Senators came out of the meeting saying that they made a lot of progress, there is work to be done to reach an agreement, Manchin says a positive meeting, moving in the right direction. Sector News Breakdown Consumer Casey General ($CASY) Q4 EPS $1.12 vs. est. 88c; Q4 revs $2.38B vs. est. $2.22B Calavo Growers ($CVGW) Q2 adj EPS $0.43 vs. est. $0.44; Q2 revs $276.82M vs. est. $267.07M; sees Q3 revs $280M-$300M vs. est. $295.8M; sees Q3 adjusted EBITDA $11M-$15M; Q2 Fresh segment revenue decreased 5%, due primarily to 9% growth in avocado volume, offset by a 10% decrease in avocado prices and 31% lower tomato revenue Limoneira ($LMNR) Q2 adj EPS 10c vs. est. 6c; Q2 revs $45.1M in-line with ests; believes it is prudent to not provide lemon guidance at this time until covid-19 vaccine is widely distributed; continues to believe avocado revenue in fiscal 2021 will be strong due to market factors and positive initial crop indicators Target Corp. ($TGT) raises its quarterly dividend by 32% to $0.90 Energy, Industrials and Materials The American Petroleum Institute ($API) showed crude oil stockpiles fell -2.1m bbl vs -3.5m expected: Cushing -420k: Gasoline +2.4m: Distillates +3.75m Air Products ($APD) and Baker Hughes (BKR) announced a strategic global collaboration to develop next generation hydrogen compression aimed at lowering the cost of production and accelerating the adoption of hydrogen as a zero-carbon fuel Ahead of its investor and analyst conference today, UPS (UPS) announced 2023 financial targets with FY23 consolidated revenue ranging from approximately $98 billion to approximately $102 billion vs. $99.92B consensus SPX Corporation ($SPXC) signs an agreement to sell 100% of the issued and outstanding stock of its wholly-owned subsidiary, SPX Transformer Solutions, to GE-Prolec Transformers, for $645 million in cash; lowers FY21 adjusted EPS view to $2.17-$2.37 from $3.06-$3.26 and lowers FY21 revenue view to $1.25B from $1.70B (est. $1.69B) ABM Industries ($ABM) Q2 adj EPS $0.82 vs. est. $0.71; Q2 revs $1.5B vs. est. $1.48B; raises year EPS view to $3.30-$3.50 from prior $3.00-$3.25 (est. $3.18); maintaining its guidance for FY 2021 Gaap income from continuing operations Boeing ($BA) seeks increase in $3.9bn Air Force One fixed-price contract; Manufacturer’s supplier problems could delay new jets for White House by a year – Financial Times reported Sherwin-Williams ($SHW) raises Q2 sales guidance and full year 2021 sales and diluted net income per share guidance; raises FY 2021 consolidated net sales guidance to be up a high-single to low-double-digit percentage over full year 2020; raises FY21 EPS view to $9.15-$9.45 from $8.80-$9.07 (est. $9.32) Global Ship Lease ($GSL) agrees to purchase 12 container ships from Borealis Finance LLC for an aggregate purchase price of $233.9M; GSL’s fleet will comprise 62 container ships with a total capacity of 322,770 TEU Vale ($VALE) said it will prepay an outstanding ~$2.5B balance related to project financing for the Nacala logistics corridor that serves the Moatize coal mine in Mozambique. Financials Cohen & Steers ($CNS) reports preliminary AUM $94.2B as of May 31; an increase of $1.4B from assets under management at April 30. The increase was due to net inflows of $760M and market appreciation of $815M, partially offset by distributions of $201M Amazon ($AMZN) is considering replacing JPMorgan (JPM) in its co-brand card deal, Bloomberg reported saying American Express (AXP) and Synchrony Financial (SYF) are being considered as an alternative UP Fintech ($TIGR)5M share Secondary priced at $24.50 Healthcare Karyopharm Therapeutics ($KPTI) announces key management changes to its commercial organization LYRA Therapeutics ($LYRA) announces positive outcome of end-of-phase 2 meeting with the FDA for lyr-210 for the treatment of chronic rhinosinusitis Option Care Health ($OPCH) 15M share Spot Secondary priced at $20.00 Technology, Media & Telecom Comtech ($CMTL) Q3 sales $139.4M vs. est. $140.7M; Q3 adj EPS 26c vs. est. loss of (1c); still sees FY adj Ebitda $74M-$76M vs. est. $74.5M; lowers FY net sales $580M-$590M from prior $610.0M-$620.0M (est. $616.4M) Pegasystems ($PEGA) expands share repurchase program to $60M UiPath ($PATH) Q1 EPS loss ($1.11) vs. (33c) last year; Q1 revs $186.2M vs. $113.1M last year Ondas Holding ($INDS)4M share Spot Secondary priced at $7.00

124 Replies 13 👍 6 🔥

profile
@PradeepB #droscrew
recently

Barrons Summary 1/2/2021 ========================= Winners GNTX LOCO FIVE : INTC cheap compared to - AVGO NVDA These seven stocks might not all look cheap on the surface, but they each meet some definition of value—and they could all outperform in the year to come. : BAC KO CVS BATRK MSGS SYY DIS Activist : Increases : ENZ LEAF GMS - Decreases MHLD Analyst Overweight BLK IMAX CDXS BABA - under perform INTC

122 Replies 12 👍 13 🔥

Key Metrics

Market Cap

107.65 M

Beta

0.59

Avg. Volume

71.55 K

Shares Outstanding

48.71 M

Yield

0%

Public Float

0

Next Earnings Date

2022-06-09

Next Dividend Date

Company Information

Enzo Biochem is a pioneer in molecular diagnostics, leading the convergence of clinical laboratories, life sciences and intellectual property through the development of unique diagnostic platform technologies that provide numerous advantages over previous standards. A global company, Enzo Biochem utilizes cross-functional teams to develop and deploy products, systems and services that meet the ever-changing and rapidly growing needs of health care today and into the future. Underpinning Enzo Biochem's products and technologies is a broad and deep intellectual property portfolio, with patent coverage across a number of key enabling technologies.

CEO: Elazar Rabbani

Website:

HQ: 60 Executive Blvd Farmingdale, 11735-4710 New York

Related News